Tata Memorial study finds Nimotuzumab increases survival in head and neck cancer Patients with head and neck cancer who received Nimotuzumab in combination with concurrent radiotherapy and cisplatin had a…
A multi-disciplinary approach in head and neck cancer Head and neck cancer is the most common cancer in males and the fifth most common in females Dr Ayan Basu, Radiation Oncologist,…
